255 studies found for:    "Diphtheria"
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
2 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
3 Completed
Has Results
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis
4 Completed
Has Results
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Conditions: Diphtheria;   Pertussis;   Tetanus;   Hepatitis B;   Haemophilus Influenzae Infections
Intervention: Biological: Quinvaxem
5 Completed
Has Results
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Conditions: Diphtheria;   Tetanus
Intervention: Biological: Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
6 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
7 Completed
Has Results
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
Conditions: Pertussis;   Whooping Cough;   Tetanus;   Lockjaw;   Diphtheria
Interventions: Biological: Acellular pertussis vaccine;   Biological: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed);   Biological: Licensed TdaP booster vaccine;   Biological: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany);   Other: Saline solution
8 Completed Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
Conditions: Pertussis;   Tetanus;   Diphtheria;   Poliomyelitis;   Hepatitis B
Interventions: Biological: Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV;   Biological: Hepatitis B vaccine
9 Completed Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Pertussis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
10 Completed
Has Results
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed
11 Recruiting Post Marketing Surveillance for ADACEL™ in South Korea
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined
12 Completed
Has Results
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
13 Active, not recruiting Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301);   Biological: Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)
14 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
15 Completed
Has Results
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed
16 Completed
Has Results
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
17 Active, not recruiting Database Surveillance Safety Study of PENTACEL® Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae
Interventions: Biological: DTaP-IPV/Hib;   Biological: Other DTap Vaccines
18 Completed Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: Shan 5;   Biological: Easy Five
19 Active, not recruiting Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis;   Meningococcal Infection;   Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Serotype b (Hib)
Interventions: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate;   Biological: Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate
20 Active, not recruiting Study of SP306 Given Intramuscularly Compared to DT BIK® Given Subcutaneously in Japanese Adolescents 11 to 12 Years Old
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed;   Biological: Diphtheria and Tetanus toxoids adsorbed

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years